NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Esperion Therapeutics,
Inc. (NASDAQ:ESPR), Oxford Immunotec Global PLC (NASDAQ:OXFD), Limoneira Co (NASDAQ:LMNR), R1 RCM Inc. (NASDAQ:RCM), Carbonite,
Inc. (NASDAQ:CARB), and Shenandoah Telecommunications Co (NASDAQ:SHEN), including updated fundamental summaries, consolidated
fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
ESPR DOWNLOAD: http://Fundamental-Markets.com/register/?so=ESPR
OXFD DOWNLOAD: http://Fundamental-Markets.com/register/?so=OXFD
LMNR DOWNLOAD: http://Fundamental-Markets.com/register/?so=LMNR
RCM DOWNLOAD: http://Fundamental-Markets.com/register/?so=RCM
CARB DOWNLOAD: http://Fundamental-Markets.com/register/?so=CARB
SHEN DOWNLOAD: http://Fundamental-Markets.com/register/?so=SHEN
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
Esperion Therapeutics, Inc. (NASDAQ:ESPR), Oxford Immunotec Global PLC (NASDAQ:OXFD), Limoneira Co (NASDAQ:LMNR), R1 RCM Inc.
(NASDAQ:RCM), Carbonite, Inc. (NASDAQ:CARB), and Shenandoah Telecommunications Co (NASDAQ:SHEN) on a fundamental level and outlines
the overall demand for their products and services in addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's
readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed August 16th,
2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ESPERION THERAPEUTICS, INC. (ESPR) REPORT OVERVIEW
Esperion Therapeutics' Recent Financial Performance
Esperion Therapeutics is expected to report earnings on November 6th, 2018. The report will be for the fiscal
period ending September 30th, 2018. The reported EPS for the same quarter last year was -$1.86. The estimated EPS forecast for the
next fiscal year is -$5.35 and is expected to report on February 19th, 2019.
To read the full Esperion Therapeutics, Inc. (ESPR) report, download it here: http://Fundamental-Markets.com/register/?so=ESPR
-----------------------------------------
OXFORD IMMUNOTEC GLOBAL PLC (OXFD) REPORT OVERVIEW
Oxford Immunotec Global's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Oxford Immunotec Global reported revenue of
$29.32MM vs $26.12MM (up 12.24%) and basic earnings per share -$0.25 vs -$0.74. For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Oxford Immunotec Global reported revenue of $103.08MM vs $86.08MM (up 19.75%) and basic earnings per share
-$1.38 vs -$1.00. Oxford Immunotec Global is expected to report earnings on October 30th, 2018. The report will be for the fiscal
period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.24. The estimated EPS forecast for the
next fiscal year is -$0.65 and is expected to report on February 26th, 2019.
To read the full Oxford Immunotec Global PLC (OXFD) report, download it here: http://Fundamental-Markets.com/register/?so=OXFD
-----------------------------------------
LIMONEIRA CO (LMNR) REPORT OVERVIEW
Limoneira's Recent Financial Performance
For the three months ended April 30th, 2018 vs April 30th, 2017, Limoneira reported revenue of $43.14MM vs
$36.89MM (up 16.92%) and basic earnings per share $0.45 vs $0.24 (up 87.50%). For the twelve months ended October 31st, 2017 vs
October 31st, 2016, Limoneira reported revenue of $121.31MM vs $111.79MM (up 8.52%) and basic earnings per share $0.42 vs $0.52
(down 19.23%). Limoneira is expected to report earnings on September 10th, 2018. The report will be for the fiscal period ending
July 31st, 2018. The reported EPS for the same quarter last year was $0.52. The estimated EPS forecast for the next fiscal year is
$0.83 and is expected to report on January 14th, 2019.
To read the full Limoneira Co (LMNR) report, download it here: http://Fundamental-Markets.com/register/?so=LMNR
-----------------------------------------
R1 RCM INC. (RCM) REPORT OVERVIEW
R1 RCM's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, R1 RCM reported revenue of $207.90MM vs $99.40MM
(up 109.15%) and basic earnings per share -$0.07 vs -$0.11. For the twelve months ended December 31st, 2017 vs December 31st, 2016,
R1 RCM reported revenue of $449.80MM vs $592.60MM (down 24.10%) and basic earnings per share -$0.75 vs $0.65. R1 RCM is expected to
report earnings on October 30th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for
the same quarter last year was -$0.08. The estimated EPS forecast for the next fiscal year is -$0.02 and is expected to report on
March 8th, 2019.
To read the full R1 RCM Inc. (RCM) report, download it here: http://Fundamental-Markets.com/register/?so=RCM
-----------------------------------------
CARBONITE, INC. (CARB) REPORT OVERVIEW
Carbonite's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Carbonite reported revenue of $77.73MM vs
$59.03MM (up 31.68%) and basic earnings per share -$0.20 vs -$0.23. For the twelve months ended December 31st, 2017 vs December
31st, 2016, Carbonite reported revenue of $239.46MM vs $206.99MM (up 15.69%) and basic earnings per share -$0.14 vs -$0.15.
Carbonite is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th,
2018. The reported EPS for the same quarter last year was $0.13. The estimated EPS forecast for the next fiscal year is $1.27 and
is expected to report on February 12th, 2019.
To read the full Carbonite, Inc. (CARB) report, download it here: http://Fundamental-Markets.com/register/?so=CARB
-----------------------------------------
SHENANDOAH TELECOMMUNICATIONS CO (SHEN) REPORT OVERVIEW
Shenandoah Telecommunications' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Shenandoah Telecommunications reported revenue of
$154.03MM vs $153.26MM (up 0.50%) and basic earnings per share $0.16 vs -$0.00. For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Shenandoah Telecommunications reported revenue of $611.99MM vs $535.29MM (up 14.33%) and basic earnings per
share $1.35 vs -$0.02. Shenandoah Telecommunications is expected to report earnings on November 1st, 2018. The report will be for
the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.07. The estimated EPS
forecast for the next fiscal year is $0.82 and is expected to report on March 21st, 2019.
To read the full Shenandoah Telecommunications Co (SHEN) report, download it here: http://Fundamental-Markets.com/register/?so=SHEN
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
